Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.
2.

Hericium erinaceus enhances doxorubicin-induced apoptosis in human hepatocellular carcinoma cells.

Lee JS, Hong EK.

Cancer Lett. 2010 Nov 28;297(2):144-54. doi: 10.1016/j.canlet.2010.05.006.

PMID:
20554107
3.

Transcriptional analysis of doxorubicin-induced cytotoxicity and resistance in human hepatocellular carcinoma cell lines.

Wang J, Chan JY, Fong CC, Tzang CH, Fung KP, Yang M.

Liver Int. 2009 Oct;29(9):1338-47. doi: 10.1111/j.1478-3231.2009.02081.x. Epub 2009 Jul 16.

PMID:
19627484
4.

The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.

Choi J, Yip-Schneider M, Albertin F, Wiesenauer C, Wang Y, Schmidt CM.

J Surg Res. 2008 Dec;150(2):219-26. doi: 10.1016/j.jss.2008.01.029. Epub 2008 Mar 3.

PMID:
18468633
5.
7.

MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells.

Fornari F, Milazzo M, Chieco P, Negrini M, Calin GA, Grazi GL, Pollutri D, Croce CM, Bolondi L, Gramantieri L.

Cancer Res. 2010 Jun 15;70(12):5184-93. doi: 10.1158/0008-5472.CAN-10-0145. Epub 2010 May 25.

8.

[Antisense oligonucleotide against survivin induces apoptosis and enhances adriamycin sensitivity of SMMC-7721/ADM cells].

Gao P, Fang CH, Zhang GQ, Yan Z.

Nan Fang Yi Ke Da Xue Xue Bao. 2006 Nov;26(11):1644-7. Chinese.

10.

Possible reduction of hepatoma formation by Smmu 7721 cells in SCID mice and metastasis formation by B16F10 melanoma cells in C57BL/6 mice by Agaricus blazei murill extract.

Wu MF, Lu HF, Hsu YM, Tang MC, Chen HC, Lee CS, Yang YY, Yeh MY, Chung HK, Huang YP, Wu CC, Chung JG.

In Vivo. 2011 May-Jun;25(3):399-404.

PMID:
21576414
11.

Expression of TNF-related apoptosis-inducing ligand in human hepatocellular carcinoma.

Shiraki K, Yamanaka T, Inoue H, Kawakita T, Enokimura N, Okano H, Sugimoto K, Murata K, Nakano T.

Int J Oncol. 2005 May;26(5):1273-81.

PMID:
15809718
12.
13.

Downregulation of NF-kappaB activation in a H4IIE transfectant insensitive to doxorubicin-induced apoptosis.

Chovolou Y, Wätjen W, Kampkötter A, Kahl R.

Toxicology. 2007 Mar 22;232(1-2):89-98. Epub 2006 Dec 17.

PMID:
17223244
14.

The role of NF-kappaB in hepatocellular carcinoma cell.

Wang J, Huang Q, Chen M.

Chin Med J (Engl). 2003 May;116(5):747-52.

PMID:
12875694
15.

Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent XIAP up-regulation.

Lin MT, Chang CC, Chen ST, Chang HL, Su JL, Chau YP, Kuo ML.

J Biol Chem. 2004 Jun 4;279(23):24015-23. Epub 2004 Mar 24.

16.

Synergistic antitumoral activity and induction of apoptosis by novel pan Bcl-2 proteins inhibitor apogossypolone with adriamycin in human hepatocellular carcinoma.

Mi JX, Wang GF, Wang HB, Sun XQ, Ni XY, Zhang XW, Tang JM, Yang DJ.

Acta Pharmacol Sin. 2008 Dec;29(12):1467-77. doi: 10.1111/j.1745-7254.2008.00901.x.

17.

Celecoxib enhances doxorubicin-induced cytotoxicity in MDA-MB231 cells by NF-kappaB-mediated increase of intracellular doxorubicin accumulation.

van Wijngaarden J, van Beek E, van Rossum G, van der Bent C, Hoekman K, van der Pluijm G, van der Pol MA, Broxterman HJ, van Hinsbergh VW, Löwik CW.

Eur J Cancer. 2007 Jan;43(2):433-42. Epub 2006 Nov 9.

PMID:
17097285
18.

Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor kappaB-mediated inducible chemoresistance.

Singh RP, Mallikarjuna GU, Sharma G, Dhanalakshmi S, Tyagi AK, Chan DC, Agarwal C, Agarwal R.

Clin Cancer Res. 2004 Dec 15;10(24):8641-7.

19.

C-Phycocyanin inhibits MDR1 through reactive oxygen species and cyclooxygenase-2 mediated pathways in human hepatocellular carcinoma cell line.

Nishanth RP, Ramakrishna BS, Jyotsna RG, Roy KR, Reddy GV, Reddy PK, Reddanna P.

Eur J Pharmacol. 2010 Dec 15;649(1-3):74-83. doi: 10.1016/j.ejphar.2010.09.011. Epub 2010 Sep 19.

PMID:
20858479
20.

MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.

Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin M, Sabbioni S, Calin GA, Grazi GL, Croce CM, Tavolari S, Chieco P, Negrini M, Bolondi L.

Cancer Res. 2009 Jul 15;69(14):5761-7. doi: 10.1158/0008-5472.CAN-08-4797. Epub 2009 Jul 7.

Supplemental Content

Support Center